Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Hydrophobic Interaction Chromatography Market Outlook

The global hydrophobic interaction chromatography market size was valued at USD 366.13 million in 2023, driven by heightened Demand for Monoclonal Antibodies. The market is estimated to grow at a CAGR of 6.9% during the forecast period 2024-2032 to attain a value of USD 667.48 million by 2032.

Heightened Demand for Monoclonal Antibodies to Propel the Global Hydrophobic Interaction Chromatography Industry

Based on sample type, the monoclonal antibodies segment is predicted to account for a significant market share in the hydrophobic interaction chromatography industry. The monoclonal antibodies are duplicated antibodies that are produced artificially through the process of genetic engineering.

Global Hydrophobic Interaction Chromatography Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The segment growth can be attributed to the increased demand for monoclonal antibodies in cancer treatment, bone marrow transplants, and other applications. In this regard, the hydrophobic interaction chromatography process is used increasingly to purify the monoclonal antibodies. These factors are predicted to aid the market growth in the coming years.

North America to Account for a Substantial Market Share in the Global Hydrophobic Interaction Chromatography Industry

North America is estimated to possess a substantial share of the hydrophobic interaction chromatography industry in the forecast period. This growth can be attributed to the rising incidences of chronic illnesses in the region, which is expected to lead to a heightened demand for antibodies development. For instance, in the US, an estimated number of 1,806,590 cancer cases were reported in 2021. In addition, the rising investments in the funding of research for hydrophobic interaction chromatography are also anticipated to aid the market growth.

Hydrophobic Interaction Chromatography: Market Segmentation

Hydrophobic interaction chromatography refers to the process of separating proteins based on their surface hydrophobicity. It is a popular method of chromatography, as it deploys a less denaturing environment, which helps keep the biological activity of the protein intact. This process also aids in removing impurities and aggregate species that may be present in a solution.

By product, the market is divided into:

  • Resins 
  • Columns
  • Buffers
  • Others

On the basis of sample type, the industry can be segmented into:

  • Monoclonal Antibodies
  • Vaccines
  • Others

Based on end user, the market can be categorised into:

  • Pharmaceutical and Biopharmaceutical Companies
  • CROs and CMOs
  • Research and Academic Institutes 
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Rising Investments in the Pharmaceutical Sector to Augment the Growth of the Global Hydrophobic Interaction Chromatography Industry

The growing capital expenditure in the pharmaceutical sector is driving the growth of the hydrophobic interaction chromatography industry. The growing geriatric population, which is more likely to contract severe ailments such as autoimmune diseases and others, is also supporting the market. In addition, the rising issues of cancer, such as breast and prostate cancer, are also expected to contribute to the industry growth in the coming years. Moreover, the technological advancements and the rising investments in research and development activities in the healthcare sector are anticipated to propel the market growth over the forecast period.

Key Industry Players in the Global Hydrophobic Interaction Chromatography Market

The report gives a detailed analysis of the following key players in the global hydrophobic interaction chromatography market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Sartorius AG
  • Tosoh Bioscience GmbH
  • Sepax Technologies, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Sample Type
  • Application
  • End User
  • Region
Breakup by Product
  • Resins
  • Columns
  • Buffers
  • Others
Breakup by Sample Type
  • Monoclonal Antibodies
  • Vaccines
  • Others
Breakup by Application
  • POC
  • Home Diagnostic
  • Research Labs
  • Environmental Monitoring
  • Food and Beverages
  • Biodefence
Breakup by End User
  • Home Healthcare Diagnostics
  • POC Testing
  • Food Industry
  • Research Laboratories
  • Security and Biodefence
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Sartorius AG
  • Tosoh Bioscience GmbH
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Cecil Instrumentation Services Ltd.
  • Hitachi High-Tech America, Inc.
  • Agilent Technologies, Inc.
  • Restek Corporation
  • PerkinElmer Inc. (U.S.)
  • JASCO Corporation
  • Hitachi High-Tech America, Inc.
  • Tosoh Bioscience
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

It is estimated that the global market for hydrophobic interaction chromatography reached a value of USD 366.13 million in 2023.

The market is anticipated to grow at a CAGR 6.9% during the forecast period of 2024-2032 to reach a value of USD 667.48 million by 2032.

The major drivers of the industry, such as the increased demand for monoclonal antibodies, rising incidences of chronic illnesses, growing geriatric population, rapid technological advancements, and the rapid investments in the funding of research for hydrophobic interaction chromatography, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the heightened capital expenditure in the pharmaceutical sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant products considered within the market report include resins, columns, buffers, and others.

The significant sample types include monoclonal antibodies, vaccines, and others.

The major end users include pharmaceutical and biopharmaceutical companies, CROs and CMOs, research and academic institutes, and others.

The major players in the industry are Bio-Rad Laboratories, Inc., GE Healthcare, Sartorius AG, Tosoh Bioscience GmbH, Sepax Technologies, Inc., and others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124